BRAF and ovarian carcinoma: For ovarian carcinoma, presence of the BRAF V600E mutation as the marker was detected from archival paraffin-embedded ovarian tissue collected at the time of diagnosis, during ctDNA monitoring, BRAF V600E associated with OC remained undetectable, aligning with remission.